Page last updated: 2024-09-03

xaliproden and Allodynia

xaliproden has been researched along with Allodynia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andoh, T; Kuraishi, Y; Sakamoto, A2

Other Studies

2 other study(ies) available for xaliproden and Allodynia

ArticleYear
Effects of xaliproden, a 5-HT₁A agonist, on mechanical allodynia caused by chemotherapeutic agents in mice.
    European journal of pharmacology, 2013, Dec-05, Volume: 721, Issue:1-3

    Topics: Animals; Antineoplastic Agents; Gene Expression Regulation; Hyperalgesia; Male; Mice; Mice, Inbred C57BL; Naphthalenes; Pyridines; Receptor, Serotonin, 5-HT1A; RNA, Messenger; Sensory Receptor Cells; Serotonin 5-HT1 Receptor Agonists; Tibial Nerve

2013
5-HT1A receptor agonists, xaliproden and tandospirone, inhibit the increase in the number of cutaneous mast cells involved in the exacerbation of mechanical allodynia in oxaliplatin-treated mice.
    Journal of pharmacological sciences, 2016, Volume: 131, Issue:4

    Topics: Animals; Cell Movement; Hyperalgesia; Isoindoles; Male; Mast Cells; Mice; Naphthalenes; Organoplatinum Compounds; Oxaliplatin; Piperazines; Pyridines; Pyrimidines; Serotonin 5-HT1 Receptor Agonists; Skin

2016